Table 1

Patient Demographics

EVEREST Integrated
High-Risk Cohort (N = 351)
Age, yrs75.7 ± 10.5 (351)
 Patients over 75 yrs of age58.1 (204/351)
Male61.0 (214/351)
Body mass index, kg/m226.9 ± 11.6 (351)
Congestive heart failure98.0 (344/351)
Coronary artery disease82.2 (287/349)
Myocardial infarction50.7 (177/349)
Angina50.8 (168/331)
Atrial fibrillation68.5 (217/317)
Cerebrovascular disease20.5 (72/351)
Stroke12.8 (45/351)
Peripheral vascular disease19.0 (66/348)
Cardiomyopathy57.5 (202/351)
Chronic obstructive pulmonary disease28.9 (101/350)
Hypertension89.5 (314/351)
Diabetes39.4 (138/350)
Moderate to severe renal disease30.5 (107/351)
Functional MR causes70.1 (246/351)
Previous cardiovascular surgery59.8 (210/351)
Previous percutaneous coronary intervention49.9 (175/331)
Cardiac rhythm device implant
 Pacemaker20.3 (69/340)
 Implantable cardioverter-defibrillator30.0 (102/340)
NYHA functional class
 I2.6 (9/351)
 II12.5 (44/351)
 III61.5 (216/351)
 IV23.4 (82/351)
LV ejection fraction47.5 ± 14.2 (318)
LV internal diameter (systole, cm)4.4 ± 1.1 (323)

Values are mean ± SD (n) or % (n/N).

LV = left ventricular; MR = mitral regurgitation; NYHA = New York Heart Association.